Addex Therapeutics (ADXN) EBIT Growth (3y) (2021 - 2025)
Addex Therapeutics (ADXN) EBIT Growth (3y) (2021 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
-1,580.97% |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
32.96% |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
-29.67% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
-50.81% |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
16.35% |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
13.47% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Addex Therapeutics |
1.08 Bn |
1.08 Bn |
- |
64.23% |
| Date | Value |
|---|
| Dec 31, 2025 |
64.23% |
| Sep 30, 2025 |
41.35% |
| Jun 30, 2025 |
50.65% |
| Mar 31, 2025 |
52.37% |
| Dec 31, 2024 |
42.81% |
| Sep 30, 2024 |
43.08% |
| Jun 30, 2024 |
41.40% |
| Mar 31, 2024 |
36.23% |
| Dec 31, 2023 |
42.84% |
| Sep 30, 2023 |
36.93% |
| Jun 30, 2023 |
47.74% |
| Mar 31, 2023 |
55.19% |
| Dec 31, 2022 |
-13.02% |
| Sep 30, 2022 |
-4.16% |
| Jun 30, 2022 |
-54.56% |
| Mar 31, 2022 |
-58.61% |
| Dec 31, 2021 |
-127.30% |
